Atlas Trials

National Cancer Center, Japan

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch National Cancer Center, Japan

RecordFirmDate
A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for Previously Treated Unresectable Thymic Carcinomas (NCT07750353)National Cancer Center, Japan2027-02-01
Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma (NCT07699939)National Cancer Center, Japan2026-07-15
A Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment. (NCT06854939)National Cancer Center, Japan2025-03-01
Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients (NCT06673628)National Cancer Center, Japan2024-12-01
First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) (NCT05832827)National Cancer Center, Japan2023-09-04
Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume) (NCT06159478)National Cancer Center, Japan2023-03-29
Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study (NCT05433753)National Cancer Center, Japan2022-05-24
Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia (NCT05217407)National Cancer Center, Japan2021-11-30
Asian Multicenter Prospective Study of ctDNA Sequencing (NCT05099978)National Cancer Center, Japan2021-11-01
A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCC (NCT04328948)National Cancer Center, Japan2020-07-01
A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma (NCT03914443)National Cancer Center, Japan2019-05-07
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY (NCT03423199)National Cancer Center, Japan2018-02-09

Track National Cancer Center, Japan automatically

Every clearance here is in the API, with alerts when new ones post.